FOR RX BANKERS: How Accurate is theDeal?
I'm looking at the quarterly rankings based on LTM deal flow, and I just wanted to ask what does everyone think?
I'm looking at the quarterly rankings based on LTM deal flow, and I just wanted to ask what does everyone think?
| +72 | PWP acquisition by Piper cancelled | 28 | 6h |
| +62 | Is my MD a grifter? 16 years, 8 firms | 21 | 1m |
| +54 | "Corporate & Investment Banking" Analyst - Why? | 39 | 2h |
| +47 | MS / GS IBD ACs London interview processes run by nationality? | 43 | 2h |
| +43 | No return offer - UPDATE. | 12 | 1d |
| +42 | What does JEF banker always think they’re EB? | 24 | 3m |
| +41 | Article: UBS Wall Street Rebuild Is a Study in Management Failure | 7 | 3d |
| +37 | Moat of modelling in PE/Finance completely vanished; | 12 | 28m |
| +29 | Lack of talent in IB! | 25 | 1d |
| +28 | What Are The Best Boutiques 2026/2027 | 16 | 1d |
Career Resources
Not very, do not think it considered out of court, deal size, or actual revenue generated from fees if I remember
There are separate league tables for out of court, but I'm unsure how they make the rankings
There are worse sources, although OOC league tables should be taken with a grain of salt since FAs are not always disclosed publicly.
Ex Rx here but still working in relevant field. Those league tables aren't worth much for reasons repeated ad nauseum.
PJT and Evercore are winning most major mandates, with lazard very relevant in retail. Moelis also doing very well and Perella will land some big ones too albeit less frequently (mostly a function of their size).
HL is also a highly entrenched name with overall very high deal flow (they are much larger than the other groups mentioned) and expectedly will reach further down market while also having some high quality mandates too - they are, by nature of their size, a volume oriented shop.
So are you saying the EB RX firms have a focus on whale hunting, while others like HL are more focused on volume?
HL has always been a creditor volume shop. They have like 5x as many people as any other Rx group.
Would you say those names you listed are seen as the top shops?
Best way to rank Rx groups.
1) PJT
1A) EVR, HL (NY)
1B) HL (LA), Moelis, Lazard
2A) PWP(Tier 2 banks 2A, 2B are pretty similiar, but brand name for PWP puts it ahead)
2B) Ducera, CVP
3A) Jefferies, GLC, Gugg, TRS
4) Else
Worth to say that any Rx group will be solid. The "Tier 3" and above groups will still get you interviews at some of the best distressed / credit shops.
Currently working at one of the above groups as an Associate, and would slightly modify to what I’ve noticed across pitches and general market (advisor landscape / investor universe) sentiment:
1) PJT, EVR, MOE: some are better positioned for certain mandates versus others, but generally speaking are the three most successful groups at the moment, all things considered
2) HL, PWP, LAZ: again, some better than others in certain spaces (e.g., HL crushes MM debtor / creditor work, particularly in niche spaces) but these three shops will generally get the call to pitch against the Tier 1 groups - sometimes they win, other times they don’t
3) CVP, Ducera, GUGG, TRS, ROTHS, GHILL: each of these shops are a solid step down from the Tier 1 and Tier 2 shops, but largely as it relates on a franchise basis. The Tier 3 shops still each have one or two rock star senior bankers each (e.g., Neil at GHILL, Genereux at TRS) who can compete on an individual basis with the Tier 1 and 2 shops - the group as a whole just cannot
Ducera down
Qui accusantium nostrum exercitationem quis nihil. Iste non occaecati magni qui. Quis ullam exercitationem et velit quasi consectetur consequuntur. Deserunt sit dignissimos vero est modi odio nulla. Doloremque molestiae et autem recusandae molestiae ipsum quisquam.
Facere voluptas consequatur iure dolorum iste quod dicta. Voluptas animi totam voluptatem iusto reprehenderit. Eos quos sed blanditiis omnis inventore esse consequatur odio. Culpa ut et est recusandae in aperiam dolorum ab. Et nihil et praesentium cumque autem. Quas sit molestiae veniam veniam repellat nam esse. Voluptatibus perferendis quasi amet aut consequatur fugiat. Ut adipisci sed et cumque totam.
Quo a dolor qui blanditiis odio nesciunt. Fugit voluptatem debitis nisi deserunt hic adipisci non. Nostrum nesciunt nesciunt maiores alias numquam. Esse similique nulla minima. Cupiditate accusamus nesciunt fuga corrupti deserunt est. Assumenda sunt distinctio nobis est beatae ipsam perspiciatis.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...